- Home
- TRS vs CERT Comparison
TRS vs CERT Comparison
Compare TRS & CERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TRS | CERT |
|---|---|---|
| Founded | 1986 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Retail: Computer Software & Peripheral Equipment |
| Sector | Industrials | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.2B |
| IPO Year | 2004 | 2020 |
Fundamental Metrics
Financial Performance| Metric | TRS | CERT |
|---|---|---|
| Price | $39.29 | $7.78 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 10 |
| Target Price | ★ $41.50 | $11.67 |
| AVG Volume (30 Days) | 347.0K | ★ 2.2M |
| Earning Date | 04-30-2026 | 05-11-2026 |
| Dividend Yield | ★ 0.44% | N/A |
| EPS Growth | ★ 400.00 | 87.50 |
| EPS | ★ 21.96 | N/A |
| Revenue | ★ $645,720,000.00 | $418,838,000.00 |
| Revenue This Year | $5.42 | $4.18 |
| Revenue Next Year | $4.27 | $5.39 |
| P/E Ratio | $1.80 | ★ N/A |
| Revenue Growth | N/A | ★ 8.75 |
| 52 Week Low | $30.43 | $4.45 |
| 52 Week High | $45.43 | $13.88 |
Technical Indicators
Market Signals| Indicator | TRS | CERT |
|---|---|---|
| Relative Strength Index (RSI) | 47.51 | 46.02 |
| Support Level | $38.42 | $6.48 |
| Resistance Level | $39.33 | $8.39 |
| Average True Range (ATR) | 0.99 | 0.32 |
| MACD | 0.05 | -0.09 |
| Stochastic Oscillator | 49.85 | 16.02 |
Price Performance
Historical ComparisonAbout TRS TriMas Corporation
TriMas Corp designs, develops and manufactures a diverse set of products for the consumer products, and industrial markets . The company operates through two segments namely: The packaging segment manufactures and distributes closure and dispensing systems. The specialty product segment manufactures and distributes steel cylinders, wellhead engines, compression systems, industrial sealing, and fasteners. The packaging segment generates majority of its revenue.
About CERT Certara Inc.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval, and increase patient access to medicines. The company has its business presence in the Americas, which is also its key revenue-generating market, EMEA, and the Asia Pacific region.